For a patient with suspected DVT and high risk of PE, presenting with leukocytosis and an elevated PT/INR, how many days should LMWH be initiated before starting Apixaban?

LMWH Duration and Transition to Apixaban

For patients with suspected DVT and high risk of PE, initiate LMWH immediately and continue for a minimum of 7 days before transitioning to apixaban 5 mg twice daily, as apixaban requires no lead-in parenteral anticoagulation period unlike other DOACs.

Apixaban-Specific Dosing Protocol

Apixaban has a unique advantage: it does NOT require initial LMWH bridging. The standard regimen is:

• 10 mg orally every 12 hours for 7 days 1
• Then 5 mg orally every 12 hours for maintenance therapy 1

This means you can start apixaban immediately without any LMWH lead-in period 1.

When LMWH is Used First (Alternative Approach)

If you choose to start with LMWH before transitioning to apixaban:

Minimum LMWH duration: 5-7 days 1, 2, 3, 4

LMWH Dosing Options:

• Enoxaparin: 1 mg/kg SC every 12 hours 1
• Dalteparin: 200 units/kg SC daily or 100 units/kg SC every 12 hours 1
• Tinzaparin: 175 units/kg SC daily 1

Critical Timing Principle:

The 5-day minimum is mandatory regardless of how quickly therapeutic anticoagulation is achieved 2. This is based on evidence showing shorter durations result in increased VTE recurrence rates 2, 3.

Special Considerations for Your Patient

Elevated PT/INR Context:

• If PT/INR is elevated due to liver dysfunction or coagulopathy, avoid warfarin entirely and proceed directly with apixaban 1
• Monitor hemoglobin, hematocrit, and platelet count every 2-3 days for the first 14 days 1

Leukocytosis Consideration:

• Leukocytosis may indicate infection, malignancy, or inflammatory process 1
• If cancer is suspected or confirmed, apixaban is preferred over warfarin 1
• In cancer patients, LMWH monotherapy (dalteparin 200 units/kg daily for 30 days, then 150 units/kg daily) is an alternative to apixaban 1

Practical Algorithm

Option 1 (Preferred for Simplicity):

1. Start apixaban 10 mg PO every 12 hours immediately 1
2. Continue for 7 days 1
3. Switch to apixaban 5 mg PO every 12 hours for maintenance 1

Option 2 (If LMWH Started First):

1. Start enoxaparin 1 mg/kg SC every 12 hours immediately 1
2. Continue LMWH for minimum 5 days 2, 3
3. On day 5-7, stop LMWH and start apixaban 10 mg PO every 12 hours 1
4. After 7 days of apixaban, reduce to 5 mg PO every 12 hours 1

Critical Pitfalls to Avoid

• Do NOT stop LMWH before day 5, even if you plan to use apixaban 2, 3
• Do NOT use edoxaban or dabigatran dosing protocols for apixaban - these require 5+ days of LMWH lead-in, but apixaban does not 1
• Do NOT delay anticoagulation while awaiting diagnostic confirmation if clinical suspicion is high 1, 5, 3
• Avoid LMWH if creatinine clearance <30 mL/min; use UFH with aPTT monitoring instead 1, 6

Monitoring Requirements

• Baseline labs: CBC, PT/INR, aPTT, creatinine 1
• Repeat CBC every 2-3 days for first 14 days 1
• No routine anti-Xa monitoring needed for LMWH in most patients 1
• Apixaban requires no routine laboratory monitoring 1